NCT01320852View on ClinicalTrials.gov

PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2013

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

PET Scan

All patients will have a PET scan as part of their pre-transplant assessment

Trial Locations (1)

H3A 1A1

McGill Univeristy Health Centre, Montreal

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT01320852 - PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC) | Biotech Hunter | Biotech Hunter